homevideos Newsearnings NewsUS biz has bottomed out; injectible plant resolution ongoing: Alembic Pharma

US biz has bottomed out; injectible plant resolution ongoing: Alembic Pharma

Alembic Pharmaceuticals’ US business has bottomed out, Shaunak Amin, managing director, told CNBC-TV18.

Profile image

By Reema Tendulkar   | Sumaira Abidi  Feb 11, 2022 5:11:41 PM IST (Published)

Listen to the Article(6 Minutes)
Alembic Pharmaceuticals’ US business has bottomed out, Shaunak Amin, managing director, told CNBC-TV18.

He further said that India business is likely to outperform the industry by 5-6 percent and there are a couple of big launches and a first to file in Q4 of FY22.
Talking about US business, Amin said that sequential quarters could see stabilisation of US business.
The company is also working towards the resolution of the injectable plant, said Amin.
On API, he said that the active pharmaceutical ingredient (API) business is a small piece relative to sales.
For the entire interview, watch the accompanying video

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change